Exhibit 107
Calculation of Filing Fee Tables
Form S-3
(Form Type)
Kiniksa Pharmaceuticals, Ltd.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered and Carry Forward Securities
| Security Type | Security Class Title | Fee Calculation or Carry Forward Rule | Amount Registered(3) | Proposed Maximum Offering Price Per Unit | Maximum Aggregate Offering Price(3) | Fee Rate | Amount of Registration Fee | Carry Forward Form Type | Carry Forward File Number | Carry Forward Initial Effective Date | Filing Fee Previously Paid In Connection with Unsold Securities to be Carried Forward | |
| Newly Registered Securities | ||||||||||||
| Fees to Be Paid | Equity | Class A Common Shares, par value $$0.000273235 per share(1) | 457(o) | - | - | - | - | - | ||||
| Fees to Be Paid | Equity | Preferred Shares(1) | 457(o) | - | - | - | - | - | ||||
| Fees to Be Paid | Debt | Debt Securities | 457(o) | - | - | - | - | - | ||||
| Fees to Be Paid | Other | Warrants | 457(o) | - | - | - | - | - | ||||
| Fees to Be Paid | Other | Units | 457(o) | - | - | - | - | - | ||||
| Fees to Be Paid | Unallocated (Universal Shelf) | (2) | 457(o) | $175,370,001 | N/A | $175,370,001 | 0.0000927 | $16,257 | ||||
| Carry Forward Securities | ||||||||||||
| Carry Forward Securities | Equity | Class A Common Shares, par value $0.000273235 per share(1) | 415(a)(6) | - | - | - | - | - | ||||
| Carry Forward Securities | Equity | Preferred Shares(1) | 415(a)(6) | - | - | - | - | - | ||||
| Carry Forward Securities | Debt | Debt Securities | 415(a)(6) | - | - | - | - | - | ||||
| Carry Forward Securities | Other | Warrants | 415(a)(6) | - | - | - | - | - | ||||
| Carry Forward Securities | Other | Units | 415(a)(6) | - | - | - | - | - | ||||
| Carry Forward Securities | Unallocated (Universal Shelf) | (2) | 415(a)(6) | $224,629,999 | N/A | $224,629,999 | 0.0001212 | - | S-3 | 333-231910 | June 10, 2019 | $27,225 |
| Total Offering Amounts | $400,000,000(4) | |||||||||||
| Total Fees Previously Paid | — | |||||||||||
| Total Fee Offsets | — | |||||||||||
| Net Fee Due | $16,257 | |||||||||||
| (1) | Includes rights to acquire Class A Common Shares or Preferred Shares under any shareholder rights plan then in effect, if applicable under the terms of any such plan. |
| (2) | An unspecified number of securities or aggregate principal amount, as applicable, is being registered as may from time to time be offered at unspecified prices and, in addition, an unspecified number of additional Class A Common Shares is being registered as may be issued from time to time upon conversion of any Debt Securities that are convertible into Class A Common Shares or pursuant to any anti-dilution adjustments with respect to any such convertible Debt Securities. |
| (3) | Estimated solely for the purpose of calculating the registration fee. No separate consideration will be received for Class A Common Shares that are issued upon conversion of Debt Securities or Preferred Shares or upon exercise of Class A Common Share Warrants registered hereunder. The aggregate maximum offering price of all securities issued pursuant to this registration statement will not exceed $400,000,000. |
| (4) | The $400,000,000 of securities registered pursuant to this registration statement includes $224,629,999 of securities (the “Unsold Securities”) registered pursuant to the Registration Statement on Form S-3 (No. 333-231910), which became effective on June 10, 2019. Pursuant to Rule 415(a)(6) under the Securities Act of 1933, as amended, the filing fees previously paid in connection with the Unsold Securities will continue to be applied to the Unsold Securities. |
